FGF2 and atherosclerosis: Because circulating oxLDL and MDA-LDL levels are greatly increased in individuals who have coronary events [5-8,23], FGF2 downregulation by oxLDL may be an important mechanism underlying the impaired angiogenic response in atherosclerosis.